Johnson & Johnson

TARIS BioMedical, Inc., a therapeutically urology company, develops treatments for patients suffering from difficult-to-treat bladder diseases. It develops therapies for debilitating conditions, including bladder cancer and overactive bladder. The company was founded in 2008 and is based in Lexington, Massachusetts. As of December 20, 2019, TARIS BioMedical, Inc. operates as a subsidiary of Janssen Research & Development, LLC.

Conor MedSystems develops innovative controlled vascular drug delivery technologies. They have initially focused on the development of drug eluting stents to treat coronary artery disease.

Vogue International LLC manufactures and distributes hair care and other personal care products. The company’s products include hair styling products; shampoos; conditioners and styling/treatment items; and bath and body products. It distributes its products to retailers through food, drug, and mass channels of distribution in the United States and internationally. The company was founded in 1987 and is based in Clearwater, Florida. As of July 18, 2016, Vogue International LLC operates as a subsidiary of Johnson & Johnson Consumer Inc.

DayTwo Ltd. develops and operates a web-based platform that provides actionable health improvement and disease prevention solutions based on gut microbiome. The company's products include additional microbiome based diagnostic and therapeutic solutions. It also provides its services through a smart phone application. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Dreem is a neurotechnology company building consumer technology that stimulates the brain to enhance human potential. The company's product, Dreem is a wearable device that enhances the quality of deep sleep. The device monitors brainwaves, analyzes user's sleep and stimulates the brain with sound in order to extend the amount of deep sleep, improving human performance throughout the day.

Cue is a revolutionary device for tracking health information at the molecular level. For the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

Inter-Grosshandel offers wide range of wholesale brand clothing

TQIntelligence, Inc. owns and operates a platform which measures the severity of the emotional distress. The platform integrates multiple data sources and offers cognitive insights into risk stratification, treatment outcomes tracking, and personalized behavioral health interventions. The company products include TQ-Intelligence, including insights from voice/speech analytics and other psychometrically sound instruments and TQ Analytics which offers solutions using existing EMR data with actionable insights. The company features include machine learning analytics, knowledge graph, and real time prediction. TQIntelligence, Inc. was founded in 2016 and is headquartered in Atlanta, Georgia.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

AYANA is a telehealth platform that offers access to mental therapy to marginalized communities by enabling virtual communication with licensed therapists through a smart matchmaking algorithm based on their cultural experiences and identity traits. Our aim is to address the severe lack of access to mental health services by people of color & LGBTQ+ communities in an effort to combat the high cost, stigma, and the poor cultural competency by the health care industry.

DePuy Synthes is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States.

InnerPulse, Inc. develops technology, devices, software protocols, and procedures to transform the treatment of cardiac arrhythmias. It offers invasive treatment that enables physicians to implant the life-saving Percutaneous Implantable Cardioverter Defibrillator within the patient's vascular system. InnerPulse, Inc. was formerly known as Interventional Rhythm Management, Inc.

Orthotaxy SAS develops and manufactures robotic systems for performing orthopedic surgery. The company was founded in 2009 and is based in La Tronche, France. As of February 20, 2018, Orthotaxy SAS operates as a subsidiary of Apsis S.A.S.

Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market.

MicroMass is a marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes. The merger of SPS and MicroMass creates one of the largest independent, full-service, multi-channel healthcare marketing and medical communications agencies in the Southeast, with unique expertise in both human health behavior and healthcare professional advocacy.

Raybaby is a baby monitor that tracks respiration and sleep pattern. It alerts when the baby has a higher respiratory rate which is associated with fever and other conditions. Raybaby also comes equipped with integrated infrared video camera which enables live video streaming even in pitch darkness, built in speakers, and audio monitoring that uses a highly sensitive microphone.

Neurotrack is on a mission to transform the diagnosis and prevention of Alzheimer’s and related dementias through its app-based Cognitive Health Program. Its digital cognitive assessments, using groundbreaking eye-tracking technology, are coupled with a personalized intervention program to empower individuals at any age to strengthen their cognitive health through “brain checkups” and targeted lifestyle behaviors. The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.

SterilMed is a contracting manufacturer that produces medical devices. SterilMed reprocesses, remanufactures, and repairs medical devices and equipment.

U.K.-based cardiovascular drug startup

mClinica provides data, analytics services, and patient programs to healthcare organizations in Asia’s emerging markets. We collect data that no one else has on pharmaceutical supply chains, patient demographics, and prescribing practices in Southeast Asia. We use that data to provide advisory services and analytics tools to public and private healthcare organizations. We also manage patient engagement platforms that help our clients to deliver access, adherence, and health education programs.

Tibotec is a biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious diseases including HIV.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules. Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005. The company was founded in 1998.

NeoStrata Company, Inc. located in Princeton, NJ, develops and markets a comprehensive range of clinically-proven, dermatologist developed skin care brands including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. Our advanced therapeutic and cosmetic dermatological products feature unsurpassed Polyhydroxy Acid technology to meet the needs of every skin type and are available worldwide through consumer outlets, physician’s offices and spas. The creators of NeoStrata Company, Inc., Drs. Van Scott and Yu are internationally recognized for making the groundbreaking discovery that Alpha Hydroxy Acids (AHAs) have profound beneficial effect on human skin. Their passion and vision led to their subsequent research which established AHAs are not only beneficial in the treatment of dermatological conditions, but are also effective in stimulating prematurely aged or damaged skin to actually rejuvenate itself, thereby revolutionizing the treatment of aging skin.

Groupe Vendome SA manufactures adult and baby skin care products.

Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market.

Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Beijing Dabao Cosmetics Co., Ltd. develops, produces, sells, and exports herbal cosmetic products in China and internationally.

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Oncochain is developing a real-world data platform in oncology to standardize, collect and aggregate anonymized data from patients who suffer from cancer. This creates the possibility to generate useful analytics that can orientate research for pharma companies and help healthcare providers deliver value-based care. Our proprietary method of collection is a web-based Oncology specific EHR that acts as a software platform creating operational data repositories for RWD studies. We greatly aid the informational flow between providers and upskill oncology professionals. We support research by reducing recruitment times in clinical trials and by creating the necessary framework for multi-centric studies design and implementation. Oncochain SaaS Analytics Tool offers much-needed RWD insights for clients like pharma companies and CROs.

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs. It sells Tracleer, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH); Opsumit, an orally available endothelin receptor antagonist; and Ventavis, an inhaled formulation of iloprost, a synthetic compound structurally similar to prostacyclin. The company also provides Veletri, an intravenous prostacyclin for the treatment of PAH to enhance exercise capacity; Zavesca, an oral capsule for the treatment of patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option; Valchlor, a topical formulation of mechlorethamine for the treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients; and Uptravi, an oral selective IP receptor agonist targeting the prostacyclin pathway in PAH. Actelion Ltd markets its products in Switzerland, the United States, Europe, Japan, and internationally. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion Ltd operates as a subsidiary of Johnson & Johnson.

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

A bio­pharmaceuti­cal company focused on the devel­opment and com­mer­cializa­tion of antibi­otics

Full Investment Portfolio: Equities: -U.S. large cap - 27.01% -U.S. mid and small cap - 6.09% -International - 20.70% Fixed income securities: -U.S. government securities - 5.28% -Corporate debt instruments - 11.90% -Non-U.S. government securities - 4.18% -Other - 3.01% Absolute return funds - 14.64% Infrastructure - 0.30% Cash and Cash Equivalents - 1.71% Other - 5.17% Founded in 1888, Abbott Laboratories is a health-care company based in the United States that provides retirement and other benefits to its qualified employees.

Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Ci:z Holdings Co.,Ltd. develops, manufactures, and sells cosmetics, health foods, beauty care products, and other products in Japan, Taiwan, Hong Kong, the United States, and internationally. The company offers skin care cosmetics, including functional cosmetics and cosmetics for skin problems for people of various ages; and supplements, food products, and other items that enhance health and beauty. It sells its products under the Dr.Ci:Labo and Genomer brand names through mail order, as well as through wholesale channels to drug stores, pharmacies, cosmetics shops, and other retail stores; and operates stores directly operated by Dr.Ci:Labo, as well as at sales areas operated by the company at department stores and shopping centers. Ci:z Holdings Co.,Ltd. was founded in 1999 and is headquartered in Tokyo, Japan.

Jagdale Industries Pvt Ltd(JIPL) is a part of the well-established and one-of-the-oldest industrial family group of Bengaluru: ‘The Jagdale family’. The roots of Jagdale go back to 1939 when Associated Drugs Company Ltd., was set up and to the contributions of Late Shri. Radhakrishna Jagdale, founder Jagdale group. JIPL has pioneered several products including unique food, beverage, nutraceutical and pharmaceutical formulations, in line with the nation’s needs and market requirements.

Calibra Medical, Inc. develops medical devices and technologies in the diabetes sector. It offers insulin delivery devices. The company was formerly known as Seattle Medical Technologies, Inc. Calibra Medical, Inc. was founded in 2004 and is based in Redwood City, California.

Suncayr has developed a colour changing sticker that tells you when your sunscreen is no longer protecting you. The sticker, "SPOT", is is put directly on the skin, and then sunscreen is applied to your whole body. When your sunscreen is protecting your skin from UV, the sticker is clear, but when your skin becomes exposed to UV, the sticker changes to purple. This will give you and your family the confidence to safely enjoy the sun!

Novira Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antiviral drugs for the treatment of chronic hepatitis B infection. It develops core and cccDNA inhibitor anti-HBV drugs. Novira Therapeutics, Inc. was formerly known as Molecmo Nanobiotechnologies, Inc. The company was incorporated in 2006 and is based in Doylestown, Pennsylvania. As of December 4, 2015, Novira Therapeutics, Inc. operates as a subsidiary of Johnson & Johnson.

Shanghai Sand Information Technology System Co., Ltd. develops and produces financial terminal equipments and multi-media equipments for financial industry. Its products include POS terminals, cash registers and IC card readers, check readers, and net communication products. The company provides various solutions, including international card and business settlement, international card acquiring bank, document and bill information image process, personal consumption loan and foreign exchange, and IC card payment/points saving systems, as well as intermediary business self-service terminals, and multi-function self-service earmark machines. It also offers system integration and technique services for finance, telecommunication, and government areas. Shanghai Sand Information Technology System Co., Ltd. was formerly known as SAND Information Technology System Co., Ltd. The company was founded in 1994 and is based in Shanghai, China.

Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications.  At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Prapela is a health and wellness company.SVS than any other infant health and wellness company in the world. It's the result of ten years of effort in the science, product development and clinical evaluation of SVS at Harvard’s Wyss Institute for Biologically Inspired Engineering, the University of Massachusetts Memorial Medical Center and Massachusetts General Hospital.

Founded in 1998, by Dr. Victor Strecher, HealthMedia® has developed a methodology and technology that effectively emulates a health coaching session, without the coach. Our one-of-a-kind programs possess the scalability of web content and deliver the efficacious outcomes a health coaching program receives.

Ci:z Holdings Co.,Ltd. develops, manufactures, and sells cosmetics, health foods, beauty care products, and other products in Japan, Taiwan, Hong Kong, the United States, and internationally. The company offers skin care cosmetics, including functional cosmetics and cosmetics for skin problems for people of various ages; and supplements, food products, and other items that enhance health and beauty. It sells its products under the Dr.Ci:Labo and Genomer brand names through mail order, as well as through wholesale channels to drug stores, pharmacies, cosmetics shops, and other retail stores; and operates stores directly operated by Dr.Ci:Labo, as well as at sales areas operated by the company at department stores and shopping centers. Ci:z Holdings Co.,Ltd. was founded in 1999 and is headquartered in Tokyo, Japan.

Gynecare offers an endometrial ablation system for the treatment of uterine disorders. Gynecare offers devices like ThermaChoice Uterine Balloon Therapy system for the treatment of women who experience dysfunctional uterine bleeding. It also offers a VersaPoint Bipolar Electrosurgery system to treat women diagnosed with benign uterine pathologies including fibroids, polyps, adhesions, and divided septa.

Biotechnology company specializing in the characterization and process engineering of complex molecules

Auris Surgical Robotics is a company that provides robotic medical care that is transforming medical intervention by introducing the monarch platform. Auris aims to leverage the power of flexible robotics to enable new possibilities in endoscopy, which uses small cameras and tools to enter the body through its natural openings. The Monarch Platform integrates the latest advancements in imaging technology, robotics, endoscope design, sensing, and data science for better outcomes and reduced costs.

DayTwo Ltd. develops and operates a web-based platform that provides actionable health improvement and disease prevention solutions based on gut microbiome. The company's products include additional microbiome based diagnostic and therapeutic solutions. It also provides its services through a smart phone application. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

BabyCenter, L.L.C. provides pregnancy and parenting information digitally to moms and dads in the United States and internationally. It offers information and advice in the areas of pregnancy, baby, toddler, preschooler, and big kid. The company also offers pregnancy products; diapering products; on the go products, such as strollers, car seats, baby carriers, and play yards; activities and play products; baby care products; nursery products; feeding products; health and safety products; and toddler products. It offers its products through Websites, mobile applications, online communities, email series, social programs, print publications, and public health initiatives. The company was founded in 1997 and is headquartered in San Francisco, California. As of August 27, 2019, BabyCenter, L.L.C. operates as a subsidiary of Everyday Health Media LLC.

Micrus Endovascular Corporation develops and manufactures both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus Endovascular develops products that can be used by interventional neuroradiologists, interventional neurologists, and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. The Micrus Endovascular product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. It also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires, and accessory products used in conjunction with its microcoils. Micrus Endovascular Corporation wasfounded in 1996 and is based in San Jose, California. As of September 27, 2010, Micrus Endovascular LLC operates as a subsidiary of Codman & Shurtleff, Inc.

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.

Mitek Surgical Products provided bone anchors and minimally invasive surgical tools for orthopedic surgery. The company was founded by three Massachusetts Institute of Technology engineers in 1985.

Verb Surgical Inc. develops a digital surgery platform that combines robotics, advanced visualization, advanced instrumentation, data analytics, and connectivity for operating room professionals. The company was incorporated in 2015 and is based in Santa Clara, California. Verb Surgical Inc. operates as a subsidiary of Johnson & Johnson Innovation - JJDC, Inc.

Zarbee's, Inc. manufactures and sells cough and throat relief, and immune support products, as well as vitamins and supplements for kids, children, and adults. It offers its products through store and online retailers. The company was founded in 2008 and is based in Draper, Utah. It has a location in Greenwich, Connecticut. As of September 14, 2018, Zarbee's, Inc. operates as a subsidiary of Johnson & Johnson Consumer Inc..

LXN Corporation is a medical technology company that develops, manufactures, and markets products to help people with diabetes better manage their disease. The company offers GlucoProtein, a home-based test that measures overall glucose control. It allows patients and healthcare professionals to better monitor the overall effectiveness of diabetes treatments and make timely and effective therapy changes. LXN Corporation was founded in 1994 and is based in San Diego, California.

At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and prevented. Bringing solutions and advancing science for the benefit of patients. They work with today’s informed and empowered patients to ensure our solutions are designed for and reach the people who need them. They work for change that will improve access to medicines: the best available treatment at an affordable price. That’s why they at Janssen strive to provide access to effective and affordable medicines and related health care services across the world.